Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$26.67 -0.08 (-0.28%)
As of: Sep 30, 2026 · 2:54 PM EDT

Arcutis Biotherapeutics (ARQT) Total Non-Current Liabilities (2019 - 2026)

Updated

Arcutis Biotherapeutics' Total Non-Current Liabilities came in at $267.53 million for Q2 2026, up 25.5% from $213.1 million a year earlier but down 0.9% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Arcutis Biotherapeutics' Total Non-Current Liabilities was $243.06 million, up 27.4% from FY2024.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of 54.6% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $190.78 million in FY2024 (-24.2%), $251.85 million in FY2023 (+5.1%), $239.69 million in FY2022 (+117.0%) and $110.45 million in FY2021 (+300.7%).
  • The five-year range for quarterly Total Non-Current Liabilities is $23.98 million (Q3 2021) to $280.29 million (Q3 2024).
  • Year-over-year, Total Non-Current Liabilities has increased for three consecutive quarters, with growth averaging 0.1% over the last seven quarters.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q3 2022 (growth of 893.0%), and the weakest in Q4 2024 (a decline of 24.2%).
  • Business Quant data shows ARQT's Total Non-Current Liabilities at $269.92 million (Q1 2026), $243.06 million (Q4 2025) and $212.54 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Arcutis Biotherapeutics 3.36 Bn 2.64 Bn 118.92 Mn 267.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 267.53 Mn
Mar 31, 2026 269.92 Mn
Dec 31, 2025 243.06 Mn
Sep 30, 2025 212.54 Mn
Jun 30, 2025 213.10 Mn
Mar 31, 2025 201.09 Mn
Dec 31, 2024 190.78 Mn
Sep 30, 2024 280.29 Mn
Jun 30, 2024 258.14 Mn
Mar 31, 2024 253.29 Mn
Dec 31, 2023 251.85 Mn
Dec 31, 2022 239.69 Mn
Sep 30, 2022 238.14 Mn
Jun 30, 2022 105.07 Mn
Mar 31, 2022 110.32 Mn
Dec 31, 2021 110.45 Mn
Sep 30, 2021 23.98 Mn
Jun 30, 2021 18.38 Mn
Mar 31, 2021 20.36 Mn
Dec 31, 2020 27.57 Mn
API Access

Arcutis Biotherapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ARQT&period=max&api_key=YOUR_API_KEY